Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis

International Journal of Antimicrobial Agents

Volumn 31, Issue 3, 2008, Pages 287-289

  Nicolle, Lindsay ^a   Duckworth, Heather ^a   Sitar, Dan ^a   Bryski, Lisa ^a   Harding, Godfrey ^a   Zhanel, George ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Levofloxacin; Pyelonephritis; Treatment

Indexed keywords

LEVOFLOXACIN;

ACUTE PYELONEPHRITIS; ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PILOT STUDY; PRIORITY JOURNAL; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; OFLOXACIN; PYELONEPHRITIS; SERUM; TIME FACTORS; URINE;

EID: 39149113450     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.10.021     Document Type: Article

References (8)

1. Croom K.F., and Goa K.L. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs 63 (2003) 2769-2802
2. Richard G.A., Klimberg I.N., Fowler C.L., Callery-D'Amico S., and Kim S.S. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology 52 (1998) 51-55
3. Lynch J.P., File T.M., and Zhanel G.G. Levofloxacin for the treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther 5 (2006) 725-742
4. Lubasch A., Keller I., Borner K., Koeppe P., and Lode H. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother 44 (2000) 2600-2603
5. Beauchamp D., and Bergeron M.G. Pharmacologic basis for the treatment of pyelonephritis. Curr Infect Dis Rep 1 (1999) 371-378
6. Frimodt-Molloer N. Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents 19 (2002) 546-553
7. Zhanel G.G., Ennis K., Vercaigne L., Gin A.S., Embil J., and Hoban D.J. Critical review of fluoroquinolones: focus on respiratory infections. Drugs 62 (2002) 13-59
8. Talan D.A., Stamm W.E., Hooton T.M., Moran G.J., Burke T., Iravani A., Reuning-Scherer J., and Church D.A. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women. JAMA 283 (2000) 1583-1590